German Merck, Pfizer in cancer immunotherapy deal

FRANKFURT (Reuters) - Germany's Merck KGaA said in Monday it struck an alliance over cancer immunotherapy drugs with Pfizer , triggering an upfront payment of $850 million by the U.S. drugmaker.

via Reuters: Health News Read More Here..